Argomenti e Notizie
con raccolte
bibliografiche su
PubMed Logo
a cura del
Dott. C.Tarozzi
Anno 22°
Num. 135
Recens. 2647
Aderiamo allo standard HONcode per l'affidabilitÓ dell'informazione medica questo sito aderisce fin dal 2004 allo standard HONcode per l'affidabilità dell'informazione medica. Verifica qui.
Rassegna - Alimenti e Calcio - Questionari - T-Score - Valore di un Test - Calcolatori - Contatti - Digitalia - Radioactivity
Ricerca nell'archivio di questo sito...
Nuova bibliografia selezionata fino al mese di luglio 2017 (recensioni 21) Ordina per Autore - Titolo - Rivista
Chin KY.
A review on the performance of osteoporosis self-assessment tool for Asians in determining osteoporosis and fracture risk.
Postgrad Med. 2017 Jul 11. doi: 10.1080/00325481.2017.1353394. [Epub ahead of print]

Morell S, Hemmeler C, Amsler F, Gross T.
Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture - a Swiss trauma center secondary prevention project.
Swiss Med Wkly. 2017 Jul 11;147:w14451. doi: smw.2017.14451. eCollection 2017 Jul 11.

Batur P, Rice S, Barrios P, Sikon A.
Clinical Update: Osteoporosis Management.
J Womens Health (Larchmt). 2017 Jul 7. doi: 10.1089/jwh.2017.6496. [Epub ahead of print]

Yoshimura H, Ohba S, Yoshida H, Saito K, Inui K, Yasui R, Ichikawa D, Aiki M, Kobayashi J, Matsuda S, Imamura Y, Sano K.
Denosumab-related osteonecrosis of the jaw in a patient with bone metastases of prostate cancer: A case report and literature review.
Oncol Lett. 2017 Jul;14(1):127-136. doi: 10.3892/ol.2017.6121. Epub 2017 May 4.

Boyce AM.
Denosumab: an Emerging Therapy in Pediatric Bone Disorders.
Curr Osteoporos Rep. 2017 Jun 22. doi: 10.1007/s11914-017-0380-1. [Epub ahead of print]

Weaver J, Sajjan S, Lewiecki EM, Harris ST.
Diagnosis and Treatment of Osteoporosis Before and After Fracture: A Side-by-Side Analysis of Commercially Insured and Medicare Advantage Osteoporosis Patients.
J Manag Care Spec Pharm. 2017 Jul;23(7):735-744. doi: 10.18553/jmcp.2017.23.7.735.

Boleto G, Dram├ę M, Lambrecht I, Eschard JP, Salmon JH.
Disease-modifying anti-rheumatic drug effect of denosumab on radiographic progression in rheumatoid arthritis: a systematic review of the literature.
Clin Rheumatol. 2017 Jul 1. doi: 10.1007/s10067-017-3722-6. [Epub ahead of print]

Tsai JN, Jiang LA, Lee H, Hans D, Leder BZ.
Effects of Teriparatide, Denosumab, or Both on Spine Trabecular Microarchitecture in DATA-Switch: a Randomized Controlled Trial.
J Clin Densitom. 2017 Jun 14. pii: S1094-6950(17)30034-3. doi: 10.1016/j.jocd.2017.05.007. [Epub ahead of print]

Mochizuki T, Yano K, Ikari K, Kawakami K, Hiroshima R, Koenuma N, Ishibashi M, Momohara S.
Effects of denosumab treatment on bone mineral density and joint destruction in patients with rheumatoid arthritis.
J Bone Miner Metab. 2017 Jul 5. doi: 10.1007/s00774-017-0848-1. [Epub ahead of print]

Uehara M, Nakamura Y, Takahashi J, Kamimura M, Ikegami S, Suzuki T, Uchiyama S, Yamaguchi T, Kosho T, Kato H.
Efficacy of Denosumab for Osteoporosis in Three Female Patients with Osteogenesis Imperfecta.
Tohoku J Exp Med. 2017;242(2):115-120. doi: 10.1620/tjem.242.115.

Miyazawa Y, Sekine Y, Syuto T, Nomura M, Koike H, Matsui H, Shibata Y, Ito K, Suzuki K.
Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab.
Anticancer Res. 2017 Jul;37(7):3667-3671.

Tortora R, Imperatore N, Capone P, Gerbino N, Rea M, Affinito G, Caporaso N, Rispo A.
FRAX Score Can Be Used to Avoid Superfluous DXA Scans in Detecting Osteoporosis in Celiac Disease: Accuracy of the FRAX Score in Celiac Patients.
J Clin Densitom. 2017 Jun 15. pii: S1094-6950(16)30192-5. doi:10.1016/j.jocd.2017.05.010. [Epub ahead of print]

Zuin M, Rigatelli G, Scaranello F, Roncon L.
Nitrates and osteoporosis: Which relationship?
Eur J Intern Med. 2017 Jun 8. pii: S0953-6205(17)30234-0. doi: 10.1016/j.ejim.2017.06.006. [Epub ahead of print]

Khosla S, Hofbauer LC.
Osteoporosis treatment: recent developments and ongoing challenges.
Lancet Diabetes Endocrinol. 2017 Jul 6. pii: S2213-8587(17)30188-2. doi: 10.1016/S2213-8587(17)30188-2.

Na WC, Lee SH, Jung S, Jang HW, Jo S.
Pelvic Insufficiency Fracture in Severe Osteoporosis Patient.
Hip Pelvis. 2017 Jun;29(2):120-126. doi:10.5371/hp.2017.29.2.120. Epub 2017 Jun 2.

Davidson E, Seal A, Doyle Z, Fielding K, McGirr J.
Prevention of osteoporotic refractures in regional Australia.
Aust J Rural Health. 2017 Jun 15. doi:10.1111/ajr.12355. [Epub ahead of print]

Miller PD.
The history of bone densitometry.
Bone. 2017 Jun 3. pii: S8756-3282(17)30191-6. doi: 10.1016/j.bone.2017.06.002. [Epub ahead of print]

Nakamura Y, Suzuki T, Kamimura M, Ikegami S, Murakami K, Uchiyama S, Taguchi A, Kato H.
Two-year clinical outcome of denosumab treatment alone and in combination with teriparatide in Japanese treatment-naive postmenopausal osteoporotic women.
Bone Res. 2017 Jun 13;5:16055. doi: 10.1038/boneres.2016.55. eCollection 2017.

Eastell R, Szulc P.
Use of bone turnover markers in postmenopausal osteoporosis.
Lancet Diabetes Endocrinol. 2017 Jul 6. pii: S2213-8587(17)30184-5. doi: 10.1016/S2213-8587(17)30184-5. [Epub ahead of print] Review.

McClung MR.
Using Osteoporosis Therapies in Combination.
Curr Osteoporos Rep. 2017 Jun 30. doi: 10.1007/s11914-017-0376-x. [Epub ahead of print] Review.

Surbone A, Vulliemoz N, Gonzalez-Rodriguez E, Chatelain JP, Lamy O.
[Osteoporosis in menopausal women between 40 and 65 years old : an algorithm for the gynaecologist].
Rev Med Suisse. 2016 Oct 26;12(536):1811-1815. French.

(Vers. 2.1)  Modificato il 12-7-2017   
questo sito aderisce ai principi HONCODE    disclaimer